SOURCE: Medical Marijuana, Inc

Medical Marijuana, Inc

December 21, 2009 00:28 ET

Medical Marijuana Incorporated Endorses President Obama's Signing of a Federal Law Removing Restrictions on the Use of Medical Marijuana in the Nation's Capitol; Medical Marijuana Inc Rolls Out Full Scale Educational Seminars in January 2010

LOS ANGELES, CA--(Marketwire - December 21, 2009) - Medical Marijuana, Inc. (PINKSHEETS: MJNA) endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.

On Thursday, December 10th, the U.S. House of Representatives approved a $1.1 trillion omnibus spending measure which included a measure that provides federal funding for the District of Columbia's medical marijuana program. This was quickly followed in an unusual Sunday vote of the Senate. Although the District's citizens had overwhelmingly approved the use of medical marijuana in a referendum in 1998, it had been languishing due to restrictions placed on it by Congress. A House-Senate conference committee agreed to remove a handful of controversial, long-standing riders from the D.C. budget, including language that had effectively banned medical marijuana use (the so-called "Barr Amendment").

In acknowledgement of this ground breaking enactment and in furtherance of its continuing vision, Medical Marijuana Inc is pleased to announce the Nationwide Launch of its Educational Seminar series beginning Jan 16 & 17, 2010 in Los Angeles, CA. Tickets can be acquired via

Don't miss our educational seminars with great speakers who are industry leaders and insiders. A wide range of topics will be addressed in a formal but fun and entertaining way. Topics include legalization, decriminalization, compliance solutions, business models, opportunities, medicinal benefits, debunking marijuana myths, simple home gardening techniques, green agricultural technologies and much more.


Medical Marijuana, Inc. has developed a suite of solutions to deliver an efficient and secure infrastructure for the Medical Marijuana Industry that will provide the tools to industry operators to effectively manage their businesses with the confidence that they are in full compliance.

Tax Collection

The Stored Value Platform System will provide verifiable solutions to manage the difficult task of revenue and taxation collection. The provisional patent pending Stored Value Platform System is further described at:

Scientific Research and Development

MJNA acquired 20 acres of land in the mountains of Southern California in order to develop a research facility targeting medical cannabis strains specific to a wide range of medical conditions. By diligently developing the most efficacious strains and matching those strains to ailments, such as glaucoma, MJNA is poised as the industry leader in medical cannabis genetic research.

About Medical Marijuana, Inc.

Medical Marijuana, Inc. recognizes the vast and unequaled opportunities that exist in the rapidly expanding medical marijuana industry. The scientific recognition of marijuana as a powerful medicine, and as an effective, non-narcotic pain reliever, has brought Medical Marijuana use to the forefront of mainstream discussion thus opening the door for safe and lucrative investment opportunities while engaging in compassionate socio-economic models.

Forward Looking Disclaimer

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties.

For Information on our National Seminar Series please email:

For Investor Relations information please email:

Contact Information